Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The manufacturers of these medications offer tools on their websites or via phone that can help patients understand whether they are covered and how to get assistance
Active, not recruiting Obesity Drug: Retatrutide Drug: Tirzepatide A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (TRIUMPH-7) The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obes
Contrary to common knowledge, patients in the subgroup with a higher BMI did not show significant weight gain (WMD = 1.21 kg, 95% CI 1.24 to 3.60, P = 0.33, I 2 = 72%) and there were no significant differences between the subgroups ( P = 0.73) (Additional file 2: Fig
Resolve all questions before using it
Next up: a possible obesity indication
Serving size is 1 Stick Pack (8.1 G), with 15 servings per container and $1.92 per serving
US$ 28.11
US$ 21.30
US$ 21.70
US$ 26.33
